Cardiology Research
Gaurav Choudhary, MD*
An International, Double-blind, Randomized, Placebo-Controlled Phase III Study to Evaluate the Effect of Dapagliflozin on Reducing CV Death or Worsening Heart Failure in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF) (DELIVER)*
Contact: Alyssa Roberti, alyssa.roberti@va.gov**
Pragmatic Evaluation of Events and Benefits of Lipid-lowering in Older Adults (PREVENTABLE)*
Contact: Rebecca Anderson, rebecca.anderson6@va.gov**
Wen-Chih Hank Wu, MD*
Rhode Island Diastolic Dysfunction-Heart Failure (RIDD-HF)*
Contact: Melanie Parent, melanie.parent@va.gov**
Peer Support to Enhance Diabetes Shared Medical Appointments: Examining Comparative Effectiveness in VA Health Systems*
Contact: Melanie Parent, melanie.parent@va.gov**
Re-purposing Probenecid for the Treatment of Heart Failure with Reduced Ejection Fraction: The Re-Prosper HF study*
Contact: Karen Evans, karen.evans7@va.gov**
Alan Morrison, MD, PhD*
IL-1B signaling promotes atherosclerotic calcification and cardiovascular riskContact: Alyssa Roberti, alyssa.roberti@va.gov**
Nishant Shah, MD, MPH*
Sarilumab for Patients with Moderate COVID-19 Disease: A Randomized Controlled Trial with a Play-The-Winner Design*
Contact: Rebecca Anderson, rebecca.anderson6@va.gov**
**These links are regular email and are not secure. Do not send personal or medical information over the internet.
